| Name | Title | Contact Details |
|---|
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
Leverage our resources to scale your practice, while maintaining your independence.
JSA Healthcare Corporation is a leading provider of high quality healthcare services. Our facilities include 34 primary care practices in the greater Tampa Bay and Orlando areas under the JSA Medical Group name.
For 60 years, EveryMind has improved the mental health and wellness of children, youth, adults, and families in the National Capital Region. Based in Rockville, MD, EveryMinds dedicated staff of professionals and volunteers work to strengthen communi...
Inteleso is a Orlando, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.